Theme · live manifest · live theme JSON

MedTech Long '24: Trump-Favorable Regs

8 tickers · $58.04B total market cap

Group: MedTech Long

The MedTech '24 Trump-Favorable Regs subtheme is built on the belief that the Trump 2.0 administration's deregulatory and innovation-forward healthcare agenda—particularly under HHS nominee RFK Jr.—will accelerate device approval, simplify reimbursement, and improve operating conditions for smaller, domestically focused, innovative medtech companies. This policy shift is seen as a rerun of the Trump 1.0 cycle which led to record medtech outperformance.

MedTech Long '24: Trump-Favorable Regs tracks 8 publicly listed stocks in this theme: CVRX, DXCM, EXAS, HQY, IBO.V, MDWD, NARI, PBM. See the constituent table for details.

Thesis update: 2025-04-14

Constituents

Build 20260520T081747

CompanyPrevious Quarter Report DateNext Expected Report DateLast Quarter Earnings Move %Earnings Move %Intra-Quarter Move %Since Last Report %Market capWeight
DexCom, Inc.DXCM
04/30/2026 (AMC)04/30/2026 (AMC)7.59%6.58%-14.95%9.13%$25.83B12.6263
Exact Sciences CorporationEXAS
02/13/2026 (AMC)0.00%1.62%$20.03B12.6263
HealthEquity, Inc.HQY
03/17/2026 (AMC)05/28/2026 (AMC)2.18%6.38%$7.15B12.6263
Inari Medical, Inc.NARI
02/26/2025 (AMC)0.00%0.00%$4.68B12.6263
MediWound Ltd.MDWD
03/05/2026 (BMO)05/27/2026 (BMO)-3.24%-2.03%$181.2M12.6263
CVRx, Inc.CVRX
05/11/2026 (AMC)05/11/2026 (AMC)-13.01%-22.84%39.80%14.04%$158.8M12.6263
Universal Ibogaine Inc.IBO.V
04/30/202304/30/20235.38%0.05%-84.99%-67.19%$1.1M12.1212
Psyence Biomedical Ltd.PBM
$74,36412.1212
Average-0.16%-5.40%-7.74%-14.67%$7.25B12.5000
Median0.00%0.05%0.00%9.13%$2.43B12.6263
Std Dev6.22%12.62%35.17%37.19%$9.49B21.9%
Min-13.01%-22.84%-84.99%-67.19%$74,36412.1212
Max7.59%6.58%39.80%14.04%$25.83B12.6263
% Positive Tickers42.86%66.67%42.86%66.67%

* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.

← All themes